Glaxo receives Approval for Bird Flu Vaccine

The LONDON press reports that GlaxoSmithKline has received permission to market a human bird flu vaccine. This is significant because it is the first pharmaceutical to receive a license for pre-pandemic use in all 27-member European Union states. Noteworthy to those of us living in the USA, the U.S. Department of Health and Human Services has ordered for 27.5 million doses. Glaxo has spent at